RS

Remi Sinha

Active Director Director DIN 09453352
DIN 09453352 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Remi Sinha

Data last updated:

Remi Sinha is a Director at Drrizer Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09453352
Primary Designation Director
Industry Chemicals
First Appointment 31 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Dec 20212021Active

Board colleagues of Remi Sinha

NameDINCompanyDesignation
Sujata Kumari09453351Drrizer Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drrizer Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Remi Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Remi Sinha

Remi Sinha currently holds 1 directorship: Drrizer Pharmaceuticals Private Limited (Director, since 31 Dec 2021).

Remi Sinha was first appointed on 31 Dec 2021 as Director at Drrizer Pharmaceuticals Private Limited.

The current boards of Remi Sinha's companies include Sujata Kumari (Drrizer Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available